Style
Deep ValueTurnover
Orientation
Concentrated long-term| # | Security | Shares | Value | % of Portfolio |
|---|---|---|---|---|
| 1 | Parabilis Medicines Inc(PBLS) | 6,412,780 | $175.5M | 15.95% |
| 2 | Beam Therapeutics Inc(BEAM) | 4,540,132 | $155.8M | 14.16% |
| 3 | Rapport Therapeutics Inc(RAPP) | 3,728,738 | $155.4M | 14.12% |
| 4 | Seaport Therapeutics Inc(SPTX) | 6,294,951 | $136.6M | 12.42% |
| 5 | Erasca Inc(ERAS) | 7,091,557 | $129.9M | 11.81% |
Latest filing, equity positions only
Quarter-over-quarter weight changes
| Sector | Prev % | Curr % | Change |
|---|---|---|---|
| Healthcare | 96.41% | 68.65% | -27.76% |
| Unclassified | 3.59% | 31.35% | +27.76% |
Quarter-over-quarter weight changes by market cap
| 6 |
| VIR Biotechnology Inc(VIR) |
| 12,694,163 |
| $129.4M |
| 11.76% |
| 7 | Maze Therapeutics Inc(MAZE) | 4,120,053 | $123.0M | 11.18% |
| 8 | Lyell Immunopharma Inc(LYEL) | 3,247,162 | $45.5M | 4.14% |
| 9 | Generate Biomedicines Inc(GENB) | 1,944,426 | $32.8M | 2.98% |
| 10 | 10X Genomics Inc(TXG) | 217,834 | $8.4M | 0.76% |
| Cap Size | Prev % | Curr % | Change |
|---|---|---|---|
| Mid Cap | 51.77% | 37.9% | -13.87% |
| Unclassified | 3.59% | 31.35% | +27.76% |
| Small Cap | 43.94% | 30.02% | -13.92% |
| Micro Cap | 0.69% | 0.73% | +0.04% |
Quarter-over-quarter position changes